BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33836675)

  • 1. Clinical characteristics and survival outcomes of malignant struma ovarii confined to the ovary.
    Li S; Yang T; Xiang Y; Li X; Zhang L; Deng S
    BMC Cancer; 2021 Apr; 21(1):383. PubMed ID: 33836675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal surgical management of well-differentiated thyroid cancer arising in struma ovarii: a series of 4 patients and a review of 53 reported cases.
    Marti JL; Clark VE; Harper H; Chhieng DC; Sosa JA; Roman SA
    Thyroid; 2012 Apr; 22(4):400-6. PubMed ID: 22181336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant struma ovarii: a population-level analysis of a large series of 68 patients.
    Goffredo P; Sawka AM; Pura J; Adam MA; Roman SA; Sosa JA
    Thyroid; 2015 Feb; 25(2):211-5. PubMed ID: 25375817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant struma ovarii: surgical, histopathological and survival outcomes for thyroid-type carcinoma of struma ovarii with recommendations for standardising multi-modal management. A retrospective case series sharing the experience of a single institution over 10 years.
    Addley S; Mihai R; Alazzam M; Dhar S; Soleymani Majd H
    Arch Gynecol Obstet; 2021 Apr; 303(4):863-870. PubMed ID: 33512594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and survival outcomes in patients with ovarian strumal carcinoid.
    Li S; Wang X; Sui X; Zhang X; Yin M; Yang J
    BMC Cancer; 2022 Oct; 22(1):1090. PubMed ID: 36280824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant struma ovarii with thyroid-type papillary and poorly differentiated carcinoma: a case report.
    Terayama N; Fujiwara S; Ueda S; Yamada T; Ohmichi M
    J Med Case Rep; 2022 Sep; 16(1):348. PubMed ID: 36176008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study on 68 cases with struma ovarii].
    Wang Y; Pan L; Huang H; Shen K; Wu M; Lang J
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):451-4. PubMed ID: 25169639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FIGO Stage IV and Age Over 55 Years as Prognostic Predicators in Patients With Metastatic Malignant Struma Ovarii.
    Li S; Yang T; Li X; Zhang L; Shi H; Cheng N; Lang J
    Front Oncol; 2020; 10():584917. PubMed ID: 33117719
    [No Abstract]   [Full Text] [Related]  

  • 9. Presentation and treatment of two cases of malignant struma ovarii.
    Obeidat RA; Alshwayyat S; Alshwayyat TA; Rjoop A; Sharqiah QM
    BMC Womens Health; 2024 Mar; 24(1):158. PubMed ID: 38443937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, clinical characteristics, and survival outcomes of ovarian strumal diseases: a retrospective cohort study.
    Li S; Hong R; Yin M; Zhang T; Zhang X; Yang J
    BMC Womens Health; 2023 Sep; 23(1):497. PubMed ID: 37726744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The largest reported papillary thyroid carcinoma arising in struma ovarii and metastasis to opposite ovary: case report and review of literature.
    Al Hassan MS; Saafan T; El Ansari W; Al Ansari AA; Zirie MA; Farghaly H; Abdelaal A
    Thyroid Res; 2018; 11():10. PubMed ID: 30061934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant struma ovarii: a case report and review of the literature.
    Osmanağaoğlu M; Bozkaya H; Reis A
    Indian J Med Sci; 2004 May; 58(5):206-10. PubMed ID: 15166470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant struma ovarii with synchronous primary papillary thyroid cancer in the neck: A case report and literature review.
    Li S; Hong R; Yang J
    Oncol Lett; 2024 Apr; 27(4):174. PubMed ID: 38455660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposed Risk Stratification and Patterns of Radioactive Iodine Therapy in Malignant Struma Ovarii.
    Egan C; Stefanova D; Thiesmeyer JW; Lee YJ; Greenberg J; Beninato T; Zarnegar R; Christos PJ; Klein IL; Fahey TJ; Finnerty BM
    Thyroid; 2022 Sep; 32(9):1101-1108. PubMed ID: 35765923
    [No Abstract]   [Full Text] [Related]  

  • 15. Struma ovarii: management and follow-up of a rare ovarian tumour.
    Wee JY; Li X; Chern BS; Chua IS
    Singapore Med J; 2015 Jan; 56(1):35-9. PubMed ID: 25640097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of malignant struma ovarii and cervical papillary thyroid carcinoma.
    Leong A; Roche PJ; Paliouras M; Rochon L; Trifiro M; Tamilia M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4599-605. PubMed ID: 24217901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant Struma Ovarii With a Predominant Component of Anaplastic Carcinoma.
    Fukunaga M; Ishibashi T; Koyama T; Onoue K; Kitai S; Tanaka K; Isonishi S
    Int J Gynecol Pathol; 2016 Jul; 35(4):357-61. PubMed ID: 26630220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missed Initial Diagnosis of Malignant Struma Ovarii Containing Follicular Thyroid Carcinoma: Metastatic Pulmonary Recurrence 17 yr After Ovariectomy.
    Cong H; Li T; Chen G; Liang Z; Liang J; Lin Y
    Int J Gynecol Pathol; 2015 Sep; 34(5):445-9. PubMed ID: 26262453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and survival outcomes in patients with primary ovarian carcinoid: A historical cohort study.
    Kong S; Sun J; Sui X; Zhang S; Qi Y; Ma Y; Li S
    Acta Obstet Gynecol Scand; 2023 Jul; 102(7):935-941. PubMed ID: 37059424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant struma ovarii--a case report and review of the literature.
    Hatami M; Breining D; Owers RL; Del Priore G; Goldberg GL
    Gynecol Obstet Invest; 2008; 65(2):104-7. PubMed ID: 17890867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.